AAAAAA
Results:
1-13
|
Results: 13
Authors:
Ryden, L
Sjoquist, PO
Wang, WD
Citation: L. Ryden et al., Pharmacological tools for the limitation of myocardial reperfusion injury - Experimental evidence, EUR H J SUP, 3(C), 2001, pp. C28-C35
Authors:
Gourine, A
Gonon, A
Sjoquist, PO
Pernow, J
Citation: A. Gourine et al., Short-acting calcium antagonist clevidipine protects against reperfusion injury via local nitric oxide-related mechanisms in the jeopardised myocardium, CARDIO RES, 51(1), 2001, pp. 100-107
Authors:
Wang, QD
Swardh, A
Sjoquist, PO
Citation: Qd. Wang et al., Relationship between ischaemic time and ischaemia/reperfusion injury in isolated Langendorff-perfused mouse hearts, ACT PHYSL S, 171(2), 2001, pp. 123-128
Authors:
Alm, P
Sharma, HS
Sjoquist, PO
Westman, J
Citation: P. Alm et al., A new antioxidant compound H-290/51 attenuates nitric oxide synthase and heme oxygenase expression following hyperthermic brain injury - An experimental study using immunohistochemistry in the rat, AMINO ACIDS, 19(1), 2000, pp. 383-394
Authors:
Segawa, D
Sjoquist, PO
Wang, QD
Gonen, A
Nordlander, M
Ryden, L
Citation: D. Segawa et al., Calcium antagonist protects the myocardium from reperfusion injury by interfering with mechanisms directly related to reperfusion: An experimental study with the ultrashort-acting calcium antagonist clevidipine, J CARDIO PH, 36(3), 2000, pp. 338-343
Authors:
Shimizu, M
Sjoquist, PO
Wang, QD
Ryden, L
Citation: M. Shimizu et al., Effects of the angiotensin AT(1) receptor blocker candesartan on myocardial ischemic/reperfusion injury, J AM S NEPH, 10, 1999, pp. S137-S142
Authors:
Shimizu, M
Wang, QD
Sjoquist, PO
Ryden, L
Citation: M. Shimizu et al., The angiotensin II AT1 receptor antagonist candesartan at antihypertensiveplasma concentrations reduces damage induced by ischemia-reperfusion, CARDIO DRUG, 13(4), 1999, pp. 347-353
Authors:
Hedlund, S
Sharma, HS
Sjoquist, PO
Westman, J
Citation: S. Hedlund et al., A new antioxidant compound H-290/51 attenuates heat shock protein (HSP 72 kD) response, edema and cell injury following acute heat exposure. An experimental study using light and electron microscopy in the rat, J THERM BIO, 24(5-6), 1999, pp. 409-414
Authors:
Morsing, P
Adler, G
Brandt-Eliasson, U
Karp, L
Ohlson, K
Renberg, L
Sjoquist, PO
Abrahamsson, T
Citation: P. Morsing et al., Mechanistic differences of various AT(1)-receptor blockers in isolated vessels of different origin, HYPERTENSIO, 33(6), 1999, pp. 1406-1413
Authors:
Shimizu, M
Wang, QD
Sjoquist, PO
Ryden, L
Citation: M. Shimizu et al., Combination of a calcium antagonist, a lipid-peroxidation inhibitor, and an angiotensin AT(1)-receptor antagonist provides additive myocardial infarct size-limiting effect in pigs, J CARDIO PH, 34(4), 1999, pp. 512-517
Authors:
Shimizu, M
Wang, QD
Sjoquist, PO
Ryden, L
Citation: M. Shimizu et al., The angiotensin II AT(1)-receptor antagonist candesartan improves functional recovery and reduces the no-reflow area in reperfused ischemic rat hearts, J CARDIO PH, 34(1), 1999, pp. 78-81
Authors:
Segawa, D
Sjoquist, PO
Nordlander, M
Wang, QD
Gonon, A
Ryden, L
Citation: D. Segawa et al., Cardiac inotropic vs. chronotropic selectivity of isradipine, nifedipine and clevidipine, a new ultrashort-acting dihydropyridine, EUR J PHARM, 380(2-3), 1999, pp. 123-128
Authors:
Wang, QD
Sjoquist, PO
Citation: Qd. Wang et Po. Sjoquist, Effects of the insurmountable angiotensin AT(1) receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts, EUR J PHARM, 380(1), 1999, pp. 13-21
Risultati:
1-13
|